Catalent Inc (CTLT)
60.33
+0.04
(+0.07%)
USD |
NYSE |
Sep 27, 16:00
60.31
-0.02
(-0.03%)
Pre-Market: 20:00
Catalent Accounts Receivable (Quarterly): 921.00M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 921.00M |
March 31, 2024 | 875.00M |
December 31, 2023 | 843.00M |
September 30, 2023 | 830.00M |
June 30, 2023 | 1.002B |
March 31, 2023 | 1.049B |
December 31, 2022 | 916.00M |
September 30, 2022 | 989.00M |
June 30, 2022 | 1.051B |
March 31, 2022 | 932.00M |
December 31, 2021 | 871.00M |
September 30, 2021 | 831.00M |
June 30, 2021 | 1.012B |
March 31, 2021 | 834.90M |
December 31, 2020 | 771.50M |
September 30, 2020 | 700.90M |
June 30, 2020 | 838.00M |
March 31, 2020 | 698.70M |
December 31, 2019 | 681.00M |
September 30, 2019 | 647.90M |
June 30, 2019 | 693.10M |
March 31, 2019 | 583.50M |
December 31, 2018 | 551.30M |
Date | Value |
---|---|
September 30, 2018 | 503.30M |
June 30, 2018 | 555.80M |
March 31, 2018 | 506.80M |
December 31, 2017 | 427.90M |
September 30, 2017 | 410.50M |
June 30, 2017 | 488.80M |
March 31, 2017 | 402.60M |
December 31, 2016 | 366.30M |
September 30, 2016 | 376.30M |
June 30, 2016 | 414.80M |
March 31, 2016 | 343.70M |
December 31, 2015 | 332.00M |
September 30, 2015 | 308.20M |
June 30, 2015 | 372.40M |
March 31, 2015 | 331.60M |
December 31, 2014 | 336.40M |
September 30, 2014 | 332.20M |
June 30, 2014 | 403.70M |
March 31, 2014 | 344.20M |
December 31, 2013 | 317.30M |
September 30, 2013 | 295.00M |
June 30, 2013 | 358.00M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
647.90M
Minimum
Sep 2019
1.051B
Maximum
Jun 2022
864.74M
Average
857.00M
Median
Accounts Receivable (Quarterly) Benchmarks
United Therapeutics Corp | 290.70M |
The Cooper Companies Inc | 739.00M |
Johnson & Johnson | 15.79B |
Merck & Co Inc | 11.64B |
BioCardia Inc | 0.01M |